home / stock / bnoef / bnoef quote
Last: | $0.006 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.006 |
High: | $0 |
Low: | $0 |
Volume: | 22,939 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.006 | $0 | $0.006 | $0 | $0 | 22,939 | 09-19-2023 |
$0.006 | $0.0034 | $0.006 | $0.006 | $0.0034 | 72,739 | 09-18-2023 |
$0.00705 | $0.006 | $0.00705 | $0.00705 | $0.006 | 2,500 | 09-15-2023 |
$0.0054 | $0.0067 | $0.0054 | $0.0067 | $0.0054 | 112,836 | 09-14-2023 |
$0.008 | $0.0054 | $0.008 | $0.008 | $0.0054 | 32,350 | 09-13-2023 |
$0.008 | $0.00725 | $0.008 | $0.008 | $0.00725 | 19,008 | 09-12-2023 |
$0.00595 | $0.00595 | $0.00595 | $0.00595 | $0.00595 | 1,300 | 09-08-2023 |
$0.0085 | $0.0085 | $0.0085 | $0.0085 | $0.0085 | 20,000 | 09-07-2023 |
$0.0085 | $0 | $0.0085 | $0 | $0 | 1,000 | 09-06-2023 |
$0.0085 | $0.00575 | $0.0085 | $0.0085 | $0.00575 | 21,150 | 09-05-2023 |
$0.0036 | $0.003 | $0.00355 | $0.0036 | $0.003 | 25,000 | 09-04-2023 |
$0.00355 | $0.003 | $0.00355 | $0.00355 | $0.003 | 25,000 | 09-01-2023 |
$0.00473 | $0.00473 | $0.00473 | $0.00473 | $0.00473 | 2,000 | 08-31-2023 |
$0.0056 | $0.0027 | $0.0056 | $0.0056 | $0.0027 | 14,000 | 08-30-2023 |
$0.0063 | $0.0036 | $0.0063 | $0.0063 | $0.0036 | 1,200 | 08-29-2023 |
$0.00585 | $0.00585 | $0.00585 | $0.00585 | $0.00585 | 1,000 | 08-24-2023 |
$0.009 | $0 | $0.009 | $0 | $0 | 50 | 08-23-2023 |
$0.009 | $0.00525 | $0.009 | $0.0099 | $0.00525 | 629,000 | 08-22-2023 |
$0.0099 | $0 | $0.0099 | $0 | $0 | 5,000 | 08-21-2023 |
$0.0099 | $0.0021 | $0.0099 | $0.0099 | $0.0021 | 186,000 | 08-18-2023 |
News, Short Squeeze, Breakout and More Instantly...
Bionomic Ltd Par Ord Company Name:
BNOEF Stock Symbol:
OTCMKTS Market:
Bionomics Limited Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs in the United States PR Newswire EASTWOOD, Australia , Jan. 5, 2022 /PRNewswire/ -- Bionomics Limited ( Bionomics or Company ), a clinical-stage biopharmaceutica...
Bionomics Limited Announces Pricing of Initial Public Offering in the United States PR Newswire ADELAIDE, Australia , Dec. 16, 2021 /PRNewswire/ -- Bionomics Limited ( Bionomics or Company ), a clinical-stage biopharmaceutical company, today announced the...
U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders PR Newswire ADELAIDE, Australia , Dec. 1, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) ( Bion...